Date Added: 27/06/2017

Date Updated: 27/06/2017

Prevention of plantar ulcers in people with diabetic peripheral neuropathy using pressure-sensing shoe insoles

Specialties: Endocrine, nutritional and metabolic - Skin disease, burns and wound care

Technology Type: Devices - Diagnostics

Stage of development: Established

Stage of EAA: Assessment Complete

Description, patients and keywords:
  • The SurroSense Rx system is a set of pressure-sensing shoe insoles that connect wirelessly to a proprietary smartwatch and is intended for people with diabetes who have mild to moderate sensory loss associated with diabetic peripheral neuropathy, or nerve damage.
  • By providing real-time alerts about plantar pressure distributions, or the area of pressure between the foot and the surface supporting it, users of the SurroSense Rx system can alter their activities in order to relieve unsafe pressures.
  • The SurroSense Rx system is used in addition to current standard-of-care treatment for the prevention of plantar ulcers in diabetic patients.
  • There is currently no available evidence that using the SurroSense Rx system prevents plantar ulcers. However, there are ongoing clinical trials that may identify patient populations that will benefit from its use.

 Keywords: Diabetes mellitus, type 1 diabetes, type 2 diabetes, foot care, diabetic foot ulcers, plantar ulcers